Prognostic impact of the aml eln2022 risk classification in patients undergoing allogeneic stem cell transplantation

HIGHLIGHTS

• who: Madlen Jentzsch from the accordance with the Declaration of HelsinkiData analyses were approved by the Institutional Review Board of the University Hospital Leipzig. have published the paper: Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation, in the Journal: (JOURNAL) of 21/Oct/2022
• what: In contrast to previous ELN risk stratification systems, the feasibility of the latest update published very recently in 2022, remains to be demonstrated, which was the main objective of the study . Next, the authors intended to improve upon the MRD adjustments.
•  

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.